Longevity
Gene Therapy Vector Design
Generate novel viral and non-viral gene therapy vector designs with target tissue tropism, payload capacity, and immunoevasion properties.
The Challenge
Why Gene Therapy Vector Design needs a new approach to generation
Gene therapy vector engineering confronts a multi-dimensional design challenge: AAV capsid sequences, lipid nanoparticle compositions, tissue-targeting ligands, and payload configurations must be simultaneously optimized for tissue tropism, payload capacity, transduction efficiency, and immune evasion. The design space is enormous — AAV capsid libraries alone contain billions of possible variants — yet current methods explore only sparse samples through directed evolution or rational modification of known serotypes.
Directed evolution discovers functional capsid variants but requires extensive screening campaigns and produces designs without mechanistic understanding of why they work. Rational design modifies known serotypes based on structural insights but is limited to incremental changes that cannot access the full sequence space. For LNP-based delivery, formulation optimization follows empirical design-of-experiments approaches that scale poorly with the number of compositional variables.
The MatterSpace Approach
How MatterSpace generates for gene therapy vector design
MatterSpace Longevity generates complete vector architectures — capsid sequences, LNP compositions, or hybrid designs — under simultaneous constraints on tissue tropism, payload capacity, transduction efficiency, and immunogenicity. Specify the target tissue, payload requirements, and safety constraints, and Longevity constructs vector designs satisfying all parameters by construction.
The Vector Design domain pack encodes capsid structure-function relationships, lipid self-assembly physics, tissue receptor targeting models, and immune recognition prediction. Users define delivery requirements and Longevity generates vector candidates with predicted tropism profiles, payload capacities, and immunogenicity assessments.
Constraint-Based Generation
Specify what the output must satisfy. MatterSpace constructs candidates that meet all constraints simultaneously.
Valid by Construction
Every output satisfies physical laws, stability criteria, and domain constraints — no post-hoc filtering needed.
MatterSpace Longevity
Powered by a domain-specific generation engine with physics-aware priors and adaptive dynamics control.
Generation Output
What MatterSpace generates
- Novel AAV capsid sequences with predicted tropism profiles
- LNP composition designs with payload capacity specifications
- Tissue-targeted vector architectures with transduction predictions
- Immunoevasive delivery vehicle candidates with safety assessments
Key Differentiators
Why MatterSpace is different
MatterSpace Longevity generates vector designs with simultaneous optimization of all delivery parameters — tropism, capacity, efficiency, and immunoevasion — resolving the sequential optimization bottleneck that limits current vector engineering. The system explores capsid sequence space and LNP composition space beyond known serotypes and established formulations, generating novel delivery vehicles for tissue targets that existing vectors cannot efficiently reach.
Same sector
Related industries
Epigenetic Reprogramming Targets
Generate novel epigenetic intervention targets and reprogramming factor combinations for controlled cellular age reversal.
ViewCellular Rejuvenation
Generate novel senolytic compound candidates and rejuvenation protocols targeting specific hallmarks of cellular aging.
ViewGet started
Start generating with MatterSpace
Whether you are exploring gene therapy vector design for the first time or scaling an existing research programme, MatterSpace generates novel candidates that satisfy your constraints by construction.
Contact us